The Vitamin K Revolution

How John Suttie Unlocked Nature's Clotting Code

1960s-Present Biochemistry Medical Science

The Mystery of the Bleeding Newborns

In the 1960s, doctors faced a heartbreaking medical mystery: otherwise healthy newborn babies would sometimes develop sudden, unexplained bleeding that could lead to severe brain damage or death.

VKDB

Vitamin K Deficiency Bleeding affected newborns randomly and severely, creating urgency for scientific understanding.

John W. Suttie

A Wisconsin biochemist who dedicated his career to solving the vitamin K puzzle and saved countless lives.

Key Historical Timeline

1930s

Henrik Dam discovers vitamin K and its role in preventing hemorrhaging in chickens.

1943

Dam receives Nobel Prize for his discovery of vitamin K.

1960s

John Suttie begins his groundbreaking research on vitamin K mechanisms.

1970s-1980s

Suttie elucidates the vitamin K cycle and its role in protein carboxylation.

The Coagulation Conundrum

For thirty years after vitamin K's discovery, scientists understood it was essential for producing clotting factors but didn't know the precise biochemical mechanism.

Vitamin K-Dependent Clotting Factors

The Central Mystery

How did vitamin K actually help create clotting proteins? What was the precise biochemical mechanism?

  • Clotting factors were known to be produced in the liver
  • Vitamin K deficiency led to impaired blood coagulation
  • The transformation process remained elusive
  • Suttie's breakthrough came from examining molecular structures

The Vitamin K Cycle: Suttie's Central Discovery

John Suttie's most significant contribution was elucidating the "vitamin K cycle"—an elegant recycling system within our cells.

The Vitamin K Cycle

Vitamin K (reduced)
Gamma-carboxylation of Glutamate
Via GGCX enzyme
Vitamin K (oxidized)
Recycling via VKOR enzyme
Key Enzyme: GGCX

Gamma-glutamyl carboxylase uses vitamin K to activate clotting proteins by converting glutamate to gamma-carboxyglutamate (Gla).

  • Creates calcium-binding sites
  • Essential for protein function
  • Enables interaction with blood vessel walls
Key Enzyme: VKOR

Vitamin K epoxide reductase recycles used vitamin K back to its active form.

  • Creates efficient cycle
  • Minimal vitamin K needed
  • Target of warfarin anticoagulant

Vitamin K-Dependent Proteins

Protein Function Impact of Deficiency
Prothrombin (Factor II) Central clotting factor in blood coagulation Increased bleeding risk, prolonged clotting time
Factors VII, IX, X Additional essential clotting factors Uncontrolled bleeding, hemorrhagic disease
Protein C & S Natural anticoagulants that prevent excessive clotting Risk of abnormal blood clots
Osteocalcin Bone formation mineralizer Weakened bones, potential link to osteoporosis
Matrix Gla Protein Inhibits soft tissue calcification Potential for arterial calcification

A Revolutionary Experiment

Suttie's elegant experiments demonstrated conclusively that vitamin K acts as a cofactor for enzymatic modification.

Experimental Procedure
  1. Preparation of liver microsomes - Isolated from rat livers
  2. Incubation with radioactive markers - C-14 labeled amino acids
  3. Vitamin K manipulation - Added to some, withheld from others
  4. Isolation and analysis - Prothrombin properties examined

Calcium Binding Capacity

Key Findings
  • Prothrombin from vitamin K-deficient systems had different molecular weight
  • Deficient prothrombin could not bind calcium effectively
  • The difference was gamma-carboxyglutamate residues
  • Vitamin K enables enzymatic conversion of glutamate to Gla
Research Reagents
Research Tool Function
Liver microsomes Cell-free system for clotting factor synthesis
Radioactive tracers Tracking vitamin K and amino acids
Warfarin VKOR inhibitor to block vitamin K recycling
Vitamin K antagonists Create deficiency models

More Than Just Clotting

Suttie's research revealed vitamin K's functions extend far beyond blood coagulation to bone and cardiovascular health.

Osteocalcin

Produced by bone-forming cells (osteoblasts), this protein requires vitamin K-dependent gamma-carboxylation to properly regulate bone mineralization.

Bone Mineralization

Matrix Gla Protein

Found in blood vessels, this protein inhibits calcification when properly activated by vitamin K, protecting against arterial stiffness.

Artery Protection

Vitamin K Forms and Functions

Dietary Sources of Vitamin K

Food Source Vitamin K Form Content (μg/100g) Absorption Notes
Kale (cooked) K1 (Phylloquinone) 530-1140 High bioavailability with fats
Spinach (raw) K1 240-1220 Bioavailability improved by cooking
Nattō (fermented soy) K2 (MK-7) ~1100 Long-lasting form with high bioavailability
Hard cheeses K2 (MK-9) 80-100 Dairy fats enhance absorption
Brussels sprouts K1 ~110 Moderate bioavailability

Conclusion and Legacy

John Suttie's work transformed vitamin K from a mysterious nutritional factor into a well-understood biological system with profound medical implications.

Newborn Protection

Virtually eliminated VKDB in developed countries

Anticoagulant Therapies

Improved warfarin and related treatments

Bone & Heart Health

Revealed connections to osteoporosis and arterial health

"An affable individual who was devoted to the advancement of science and health-related research with a wry sense of humor that probably reflected his roots as a Wisconsin farm boy."

Colleagues remembering John Suttie 5

References